biguanides has been researched along with Fatty Liver, Nonalcoholic in 1 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Excerpt | Relevance | Reference |
---|---|---|
" A multivariate analysis with multiple logistic regression revealed that visceral fat accumulation was inhibited in women and those taking statins or thiazolidines and aggravated in men and those with obesity or an increased waist circumference." | 3.80 | Estimation of visceral fat and fatty liver disease using ultrasound in patients with diabetes. ( Ichikawa, T; Kohno, S; Nakao, K; Onitsuka, Y; Takeshima, F, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Onitsuka, Y | 1 |
Takeshima, F | 1 |
Ichikawa, T | 1 |
Kohno, S | 1 |
Nakao, K | 1 |
1 other study available for biguanides and Fatty Liver, Nonalcoholic
Article | Year |
---|---|
Estimation of visceral fat and fatty liver disease using ultrasound in patients with diabetes.
Topics: Aged; Biguanides; Body Composition; Body Mass Index; Diabetes Mellitus, Type 2; Diet, Western; Femal | 2014 |